This vaccine will be the first indigenous recombinant chimeric malaria vaccine that will be specifically designed to target two critical stages of Plasmodium falciparum, the parasite responsible for ...

AdFalciVax is a unique malaria vaccine that targets two key stages of Plasmodium falciparum, the parasite responsible for the ...

India's ICMR has developed AdFalciVax, a recombinant malaria vaccine targeting two critical stages of Plasmodium falciparum. Showing promise in preclinical trials, it aims to reduce transmission and ...

ICMR-developed vaccine targets two parasite stages, offers potential for long-term immunity and lower transmission ...

Global fight against malaria, challenges, and innovative vaccine development to eliminate the ancient foe by 2030 in India.

AdFalciVax may offer advantages such as broader protection and a lower risk of immune evasion compared to existing ...

Currently licensed and approved malaria subunit vaccines provide modest, short-lived protection against malaria. Immunization with live-attenuated Plasmodium falciparum malaria parasites is an alte ...

A new malaria vaccine achieves an unparalleled 89% efficacy by targeting late-liver-stage antigens, unlocking new horizons in the fight against global disease. Study: Safety and Efficacy of ...

A new hope for India to curb vector-borne disease, the first indigenous malaria vaccine has reportedly shown excellent ...